Ashraf Alzaabi, Nasser Al Busaidi, Rohit Pradhan, Fathelrahman Shandy, Naseem Ibrahim, Moulham Ashtar, Khaled Khudadah, Khaled Hegazy, Mohamed Samir, Mohamed Negm, Hisham Farouk, Arwa Al Khalidi, Maarten Beekman
BACKGROUND: The overuse of short-acting β2 -agonists (SABA) is associated with poor asthma control. However, data on SABA use in the Gulf region are limited. Herein, we describe SABA prescription practices and clinical outcomes in patients with asthma from the Gulf cohort of the SABA use IN Asthma (SABINA) III study. METHODS: In this cross-sectional study conducted at 16 sites across Kuwait, Oman, and the United Arab Emirates, eligible patients (aged ≥ 12 years) with asthma were classified based on investigator-defined disease severity guided by the 2017 Global Initiative for Asthma report and by practice type, i...
July 7, 2022: Asthma Research and Practice